Natalizumab Completed Phase N/A Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01071512Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis